Provenance Biopharmaceuticals Corp. Announces $8 Million Financing Arrangement
12/28/2011 6:36:28 AM
More...
|
Provenance Biopharmaceuticals Corp. Announces License Agreement with Merck Serono for the Development and Commercialization of Novel Immunocytokine for the Treatment of Cancer
3/19/2009 10:39:45 AM
More...
|